Opportunity Information: Apply for RFA CA 23 020
The NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required) funding opportunity (RFA-CA-23-020) is a National Cancer Institute cooperative agreement meant to build practical, on-the-ground infrastructure for running large, multi-center cancer screening clinical trials and related studies. It is one of three coordinated FOAs that together form the Cancer Screening Research Network (CSRN), an initiative designed to make it easier to launch and execute national screening research by relying on real-world healthcare settings and routine care populations. The core idea is to strengthen the country s ability to enroll and follow large and diverse groups of participants so researchers can rigorously evaluate screening approaches, improve early detection, and ultimately reduce cancer incidence as well as cancer-related illness and deaths.
The ACCESS Hub concept focuses on the parts of screening research that often determine whether a trial succeeds or fails: accrual and enrollment of participants, and the availability and performance of screening sites. In practice, this means creating or expanding a network of clinical and community-connected sites that can identify eligible participants, support informed consent, deliver screening interventions or procedures, and collect high-quality data in a consistent way across locations. Because this is a UG1 cooperative agreement, the work is expected to be done in close partnership with NCI, with substantial programmatic involvement from the funder to coordinate activities across the broader CSRN and to ensure that trials are implemented efficiently and with consistent standards.
The CSRN is explicitly designed to take advantage of large, heterogeneous populations who are already receiving routine care across many types of healthcare environments. That emphasis reflects a push toward studies that are more representative of the U.S. population and that can be carried out in settings where screening actually happens, rather than only in highly specialized research centers. The network is intended to support studies that test and compare cancer screening strategies, including evaluation of emerging screening modalities, with the overall goal of improving the effectiveness, reach, and equity of cancer screening. By creating a durable infrastructure for multi-center work, the program aims to shorten the time it takes to initiate trials, increase enrollment capacity, and improve the reliability and generalizability of results.
Eligible applicants are broad and include many types of public and private organizations. Standard eligibility categories listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized governments; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant types that align with the goal of reaching diverse populations and community-based care settings, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, tribal governments other than federally recognized, and U.S. territories or possessions.
Foreign organizations and foreign institutions are not eligible to apply as applicants, and non-U.S. components of U.S. organizations are not eligible to apply. However, foreign components as defined by the NIH Grants Policy Statement are allowed, meaning a U.S.-based awardee could potentially include certain foreign activities or collaborations if they meet NIH policy definitions and are justified within the project.
Administratively, the opportunity is issued by the National Institutes of Health (NIH) under CFDA numbers 93.393, 93.394, and 93.399, and it falls under the education and health funding activity category. The funding instrument is a cooperative agreement, reflecting a model where NCI is actively involved in the conduct and coordination of the program rather than acting solely as a passive funder. The original application due date listed is February 28, 2023, and the award ceiling shown is $750,000. Overall, the ACCESS Hub FOA is best understood as an infrastructure-building award focused on participant accrual and screening site readiness so that the CSRN can reliably conduct national, multi-site cancer screening trials that are faster to launch, more diverse in enrollment, and better positioned to test both established and emerging screening approaches.Apply for RFA CA 23 020
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.399.
- This funding opportunity was created on 2022-11-17.
- Applicants must submit their applications by 2023-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
Previous opportunity: U.S. AMBASSADORS FUND FOR CULTURAL PRESERVATION (AFCP)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 020
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 020) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required) Apply for RFA CA 23 021 Funding Number: RFA CA 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required) Apply for RFA CA 23 022 Funding Number: RFA CA 23 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Apply for PAR 23 052 Funding Number: PAR 23 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) Apply for PAR 23 051 Funding Number: PAR 23 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 004 Funding Number: RFA CA 23 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 003 Funding Number: RFA CA 23 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 005 Funding Number: RFA CA 23 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 23 009 Funding Number: RFA CA 23 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 23 008 Funding Number: RFA CA 23 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 23 007 Funding Number: RFA CA 23 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 23 010 Funding Number: RFA CA 23 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 002 Funding Number: RFA CA 23 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 23 006 Funding Number: RFA CA 23 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 23 011 Funding Number: RFA CA 23 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) Apply for PAR 23 058 Funding Number: PAR 23 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional) Apply for RFA DA 24 010 Funding Number: RFA DA 24 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) Apply for PAR 23 059 Funding Number: PAR 23 059 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 23 055 Funding Number: PAR 23 055 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 23 056 Funding Number: PAR 23 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) Apply for RFA DA 24 014 Funding Number: RFA DA 24 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 020", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
